X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/mallinckrodt-announces-us-fda-approval-of-supplemental-new-drug-application-for-acthar-gel-repository-corticotropin-injection-single-dose-pre-filled-selfject-injector-302077212.html
https://www.prnewswire.com/news-releases/mallinckrodt-to-present-new-retrospective-data-on-effect-of-acthar-gel-repository-corticotropin-injection-to-reduce-corticosteroid-use-and-burden-for-advanced-sarcoidosis-at-the-academy-of-managed-care-pharmacy-amcp-2023-annu-301776788.html
https://www.fiercepharma.com/marketing/ani-focuses-data-insights-ramp-its-arthritis-and-ms-flare-therapy
https://www.prnewswire.com/news-releases/retrospective-study-on-real-world-treatment-patterns-and-outcomes-of-acthar-gel-repository-corticotropin-injection-in-patients-with-refractory-rheumatoid-arthritis-published-in-drugs-in-context-301511333.html
https://www.prnewswire.com/news-releases/purified-cortrophin-gel-available-through-alliancerx-walgreens-prime-for-patients-with-certain-chronic-autoimmune-disorders-301446385.html
https://investor.anipharmaceuticals.com/news/news-details/2021/ANI-Pharmaceuticals-Announces-FDA-Approval-of-Purified-Cortrophin-Gel-for-Multiple-Indications-Including-Multiple-Sclerosis-Rheumatoid-Arthritis-and-Nephrotic-Syndrome/default.aspx
https://www.businesswire.com/news/home/20210629005106/en/Glycomine%E2%80%99s-Natural-History-Study-Informs-Potentially-Lifesaving-Update-to-Standard-of-Care-for-PMM2-CDG-Patients
https://www.prnewswire.com/news-releases/ani-receives-refusal-to-file-letter-from-fda-for-cortrophin-gel-301048877.html
https://www.prnewswire.com/news-releases/ani-announces-fda-acceptance-of-supplemental-filing-for-cortrophin-gel-80-uml-301039194.html
https://www.prnewswire.com/news-releases/mallinckrodt-announces-publication-of-new-data-on-acthar-gel-repository-corticotropin-injection-in-rheumatoid-arthritis-systemic-lupus-erythematosus-and-dermatomyositispolymyositis-published-in-open-access-rheumatology-resea-301016020.html
https://www.cnbc.com/2019/11/05/mallinckrodt-receives-sec-subpoena-over-acthar-gel-lawsuit.html
https://www.fiercepharma.com/pharma/mallinckrodt-hit-new-kickback-charges-one-day-after-15-5m-settlement-feds
https://www.reuters.com/article/us-mallinckrodt-doj/mallinckrodt-to-settle-u-s-drug-marketing-probe-fight-kickback-case-idUSKCN1T6263
https://www.fiercepharma.com/pharma/mallinckrodt-sues-to-protect-its-medicaid-reimbursement-formula-for-acthar-gel
https://www.prnewswire.com/news-releases/mallinckrodt-lupus-phase-4-clinical-study-for-acthar-gel-repository-corticotropin-injection-completes-enrollment-in-difficult-to-manage-population-300836031.html
https://www.statnews.com/pharmalot/2018/06/29/medicare-mallinckrodt-acthar-payments-doctors/
http://www.pmlive.com/pharma_news/mallinckrodt_pays_$1.2bn_for_sucampo_pharma_1215000
http://www.prnewswire.com/news-releases/mallinckrodt-highlights-first-patients-in-company-sponsored-prospective-observational-registry-on-the-use-of-hp-acthar-gel-repository-corticotropin-injection-following-acute-multiple-sclerosis-relapse-300464265.html
https://www.washingtonpost.com/news/wonk/wp/2017/01/18/maker-of-34000-a-vial-drug-to-pay-100-million-for-allegedly-preventing-competition/?utm_term=.b4fda52bb4f8
http://www.prnewswire.com/news-releases/mallinckrodt-will-initiate-company-sponsored-clinical-trial-of-hp-acthar-gel-in-treatment-of-amyotropic-lateral-sclerosis-als-300366404.html
http://www.prnewswire.com/news-releases/ani-pharmaceuticals-closes-transaction-to-acquire-two-ndas-from-merck-for-75-million-300198787.html
http://www.prnewswire.com/news-releases/mallinckrodt-study-shows-acthar-reduces-disease-activity-in-patients-with-persistently-active-systemic-lupus-erythematosus-300174549.html
http://www.prnewswire.com/news-releases/ani-pharmaceuticals-to-acquire-two-ndas-from-merck-for-75-million-300145957.html
http://www.biospace.com/News/plant-extract-fights-brain-tumor-max-planck/364538/source=Featured
Market Place
Share 
